期刊簡(jiǎn)介預(yù)計(jì)審稿時(shí)間： 約3月

The aim of Pharmacoepidemiology and Drug Safety is to provide an international forum for the communication and evaluation of data, methods and opinion in the discipline of pharmacoepidemiology. The Journal publishes peer-reviewed reports of original research, invited reviews and a variety of guest editorials and commentaries embracing scientific, medical, statistical, legal and economic aspects of pharmacoepidemiology and post-marketing surveillance of drug safety. Appropriate material in these categories may also be considered for publication as a Brief Report.

Particular areas of interest include:

design, analysis, results, and interpretation of studies looking at the benefit or safety of specific pharmaceuticals, biologics, or medical devices, including studies in pharmacovigilance, postmarketing surveillance, pharmacoeconomics, patient safety, molecular pharmacoepidemiology, or any other study within the broad field of pharmacoepidemiology;

comparative effectiveness research relating to pharmaceuticals, biologics, and medical devices. Comparative effectiveness research is the generation and synthesis of evidence that compares the benefits and harms of alternative methods to prevent, diagnose, treat, and monitor a clinical condition, as these methods are truly used in the real world;

methodologic contributions of relevance to pharmacoepidemiology, whether original contributions, reviews of existing methods, or tutorials for how to apply the methods of pharmacoepidemiology;

assessments of harm versus benefit in drug therapy;

patterns of drug utilization;

relationships between pharmacoepidemiology and the formulation and interpretation of regulatory guidelines;

evaluations of risk management plans and programmes relating to pharmaceuticals, biologics and medical devices.

《藥物流行病學(xué)與藥物安全》旨在為藥物流行病學(xué)領(lǐng)域的數(shù)據(jù)、方法和觀點(diǎn)的交流與評(píng)估提供一個(gè)國(guó)際論壇。該期刊發(fā)表同行評(píng)審的原創(chuàng)研究報(bào)告、受邀評(píng)論以及各種客座社論和評(píng)論，涵蓋藥物流行病學(xué)和藥物安全上市后監(jiān)測(cè)的科學(xué)、醫(yī)學(xué)、統(tǒng)計(jì)、法律和經(jīng)濟(jì)方面。這些類別中的適當(dāng)材料也可考慮作為簡(jiǎn)報(bào)發(fā)表。

特別感興趣的領(lǐng)域包括：

研究特定藥物、生物制劑或醫(yī)療器械的益處或安全性的研究的設(shè)計(jì)、分析、結(jié)果和解釋，包括藥物警戒、上市后監(jiān)測(cè)、藥物經(jīng)濟(jì)學(xué)、患者安全、分子藥物流行病學(xué)或藥物流行病學(xué)廣泛領(lǐng)域內(nèi)的任何其他研究；

與藥物、生物制劑和醫(yī)療器械有關(guān)的比較有效性研究。比較效果研究是生成和綜合證據(jù)，比較預(yù)防、診斷、治療和監(jiān)測(cè)臨床狀況的替代方法的益處和危害，因?yàn)檫@些方法確實(shí)在現(xiàn)實(shí)世界中使用；

與藥物流行病學(xué)相關(guān)的方法學(xué)貢獻(xiàn)，無論是原創(chuàng)貢獻(xiàn)、現(xiàn)有方法的評(píng)論，還是如何應(yīng)用藥物流行病學(xué)方法的教程；

藥物治療中的危害與益處評(píng)估；

藥物使用模式；

藥物流行病學(xué)與監(jiān)管指南的制定和解釋之間的關(guān)系；

與藥品、生物制劑和醫(yī)療器械有關(guān)的風(fēng)險(xiǎn)管理計(jì)劃和方案的評(píng)估。

《Pharmacoepidemiology And Drug Safety》(藥物流行病學(xué)和藥物安全)編輯部通訊方式為JOHN WILEY & SONS LTD, THE ATRIUM, SOUTHERN GATE, CHICHESTER, ENGLAND, W SUSSEX, PO19 8SQ。如果您需要協(xié)助投稿或潤(rùn)稿服務(wù)，您可以咨詢我們的客服老師。我們專注于期刊咨詢服務(wù)十年，熟悉發(fā)表政策，可為您提供一對(duì)一投稿指導(dǎo)，避免您在投稿時(shí)頻繁碰壁，節(jié)省您的寶貴時(shí)間，有效提升發(fā)表機(jī)率，確保SCI檢索（檢索不了全額退款）。我們視信譽(yù)為生命，多方面確保文章安全保密，在任何情況下都不會(huì)泄露您的個(gè)人信息或稿件內(nèi)容。